Minority inclusion in randomized clinical trials of panic disorder

Journal of Anxiety Disorders

Volumn 26, Issue 5, 2012, Pages 574-582

  Mendoza, Dorian B ^a   Williams, Monnica T ^b   Chapman, Kevin L ^b   Powers, Mark ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c SOUTHERN METHODIST UNIVERSITY   (United States)

Author keywords

African Americans; Anxiety; Asian Americans; Clinical trials; Ethnic differences; Hispanic Americans; Panic disorder

Indexed keywords

ADVERTIZING; AFRICAN AMERICAN; ASIAN AMERICAN; CAUCASIAN; CULTURAL FACTOR; ETHNIC DIFFERENCE; ETHNIC GROUP; EUROPEAN AMERICAN; HISPANIC; HUMAN; MINORITY GROUP; NEGRO; NON HISPANIC; OUTCOME ASSESSMENT; PANIC; PATIENT REFERRAL; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYMPTOM;

AFRICAN AMERICANS; ASIAN AMERICANS; HISPANIC AMERICANS; HUMANS; PANIC DISORDER; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84863415638     PISSN: 08876185     EISSN: 18737897     Source Type: Journal    
DOI: 10.1016/j.janxdis.2012.02.011     Document Type: Review

References (67)

1. Alegría M., Takeuchi D., Canino G., Duan N., Shrout P., Meng X.-L., et al. Considering context, place, and culture: the National Latino and Asian American Study. International Journal of Methods in Psychiatric Research 2004, 13(4):208-220.
2. Alegría M., Vila D., Woo M., Canino G., Takeuchi D., Vera M., et al. Cultural relevance and equivalence in the NLAAS instrument: integrating Etic and Emic in the development of cross-cultural measures for a psychiatric epidemiology and services study of Latinos. International Journal of Methods in Psychiatric Research 2004, 13(4):270-288.
3. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, Author, Washington, DC. revised 4th ed.
4. Asnaani A., Richey J., Dimaite R., Hinton D., Hofmann S.G. A cross-ethnic comparison of lifetime prevalence rates of anxiety disorders. Journal of Nervous and Mental Disorders 2010, 198(8):551-555. 10.1097/NMD.0b013e318ea169f.
5. Ballenger J.C., Wheadon D.E., Steiner M., Bushnell W., Gergel I.P. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. American Journal of Psychiatry 1998, 155:36-42.
6. Barlow D.H., Gorman J.M., Shear K., Woods S.W. Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: a randomized controlled trial. Journal of the American Medical Association 2000, 283(19):2529-2536.
7. Barrera T.L., Wilson K.P., Norton P.J. The experience of panic symptoms across racial groups in a student sample. Journal Anxiety Disorders 2010, 24(8):873-878.
8. Beck J.G., Stanley M.A., Baldwin L.E., Deagle E.A., Averill P.M. Comparison of cognitive therapy and relaxation training for panic disorder. Journal of Consulting and Clinical Psychology 1994, 62:818-826.
9. Behar E., McHugh R.K., Peckham A., Otto M.W. d-Cycloserine for the augmentation of an attentional training intervention for trait anxiety. Journal of Anxiety Disorders 2010, 24:440-445.
10. Black D.W., Wesner R., Bowers W., Gabel J. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Archives of General Psychiatry 1993, 50:44-50.
11. Breslau J., Aguilar-Gaxiola S., Kendler K.S., Su M., Williams D., Kessler R.C. Specifying race-ethnic differences in risk for psychiatric disorder in a USA national sample. Psychological Medicine 2006, 36(1):57-68. 10.1017/S0033291705006161.
12. Feske U., Goldstein A.J. Eye movement desensitization and reprocessing treatment for panic disorder: a controlled outcome and partial dismantling study. Journal of Consulting and Clinical Psychology 1997, 65(6):1026-1035.
13. Fisher C.B., Hoagwood K., Boyce C., Duster T., Frank D.A., Grisso T., et al. Research ethics for mental health science involving ethnic minority children and youth. American Psychologist 2002, 57:1024-1039.
14. Friedman S., Hatch M., Paradis C.M. Characteristics of African-American and White patients with panic disorder and agoraphobia. Hospital Community Psychiatry 1994, 45:798-803.
15. Friedman S., Paradis C. Panic disorder in African-Americans: symptomatology and isolated sleep paralysis. Culture, Medicine, & Psychiatry 2002, 26(2):179-198.
16. Gallagher-Thompson D., Solano N., Coon D., Arean P. Changes in indices of distress among Latino and Anglo female caregivers of elderly relatives with dementia: site-specific results from the REACH National Collaborative Study. Gerontologist 2003, 43:45-51.
17. Gamble V.N. Under the shadow of Tuskegee: African Americans and health care. American Journal of Public Health 1997, 87(11):1773-1778.
18. Gee C.B. Assessment of anxiety and depression in Asian American youth. Journal of Clinical Child and Adolescent Psychology 2004, 33(2):269-271.
19. Goldstein A.J., de Beurs E., Chambless D.L., Wilson K.A. EMDR for panic disorder with agoraphobia: comparison with waiting list and credible attention placebo control conditions. Journal of Consulting and Clinical Psychology 2000, 68:947-956.
20. Guarnaccia P.J. A cross-cultural perspective in anxiety disorders. Cultural issues in the treatment of anxiety 1997, 3-20. Guilford Press, New York. S. Friedman (Ed.).
21. Heurtin-Roberts S., Snowden L., Miller L. Expressions of anxiety in African Americans: ethnography and the epidemiological catchment area studies. Culture, Medicine, and Psychiatry 1997, 21:337-363.
22. Hicks T.V., Leitenberg H., Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Physical, mental, and social catastrophic cognitions as prognostic factors in cognitive-behavioral and pharmacological treatments for panic disorder. Journal of Consulting and Clinical Psychology 2005, 73(3):506-514.
23. Hinton D.E., Lewis-Fernandez R., Pollack M.H. A model of the generation of ataque de nervios: the role of fear of negative affect and fear of arousal symptoms. CNS Neuroscience & Therapeutics 2009, 15(3):264-275. 10.1111/j.1755-5949.2009.00101.x.
24. Horwath E., Johnson J., Hornig C.D. Epidemiology of panic disorder. Anxiety disorders in African-Americans 1994, 53-64. Springer, New York. S. Friedman (Ed.).
25. Hoehn-Saric R., McLeod D.R., Hiplsey P.A. Effect of fluvoxamine on panic disorder. Journal of Clinical Psychology 1993, 13(5):321-326.
26. Humes K.R., Jones N.A., Ramirez R.R. Overview of race and Hispanic origin: 2010 (C2010BR-02) 2011, U.S. Census Bureau, Economics and Statistics Administration, Washington, DC.
27. Hunter L.R., Schmidt N.B. Anxiety psychopathology in African American adults: literature review and development of an empirically informed sociocultural model. Psychological Bulletin 2010, 136(2):211-235.
28. Karno M., Golding J.M., Burnham M.A., Hough R.L., Escobar J.I., Wells K.M., et al. Anxiety disorders among Mexican Americans and non-Hispanic whites in Los Angeles. Journal of Nervous and Mental Disease. 1989, 177:202-209.
29. Keough M.E., Timpano K.R., Schmidt N.B. Ataques de nervios: culturally bound and distinct from panic attacks?. Depression and Anxiety 2009, 26(1):16-21. 10.1002/da.20498.
30. Kessler R.C., Berglund P., Delmer O., Jin R., Merikangas K.R., Walters E.E. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6):593-602.
31. Kessler R.C., Chiu W.T., Delmer O., Walters E.E. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry 2005, 62(6):617-627.
32. Kirmayer L.J., Young A., Hayton B.C. The cultural context of anxiety disorders. The psychiatric clinics of North America 1995, 503-521. Saunders, Philadelphia. R.D. Alarcon (Ed.).
33. Kleinknecht R.A., Dinnel D.L., Kleinknecht E.E. Cultural factors in social anxiety: a comparison of social phobia symptoms and Taijin Kyofusho. Journal of Anxiety Disorders 1997, 11(2):157-177.
34. Lin K., Cheung F. Mental health issues for Asian Americans. Psychiatric Services 1999, 50:774-780.
35. Lee J., Lei A., Sue S. The current state of mental health research on Asian Americans. Journal of Human Behavior in the Social Environment 2001, 3:159-178.
36. Londborg P.D., Wolkow R., Smith W.T., DuBoff E., England D., .Weise C. Sertraline in the treatment of panic disorder: a multi-site, double-blind, placebo-controlled, fixed-dose investigation. British Journal of Psychiatry 1998, 173:54-60.
37. Malgady R.G., Costantino G. Symptom severity in bilingual Hispanics as a function of clinician ethnicity and language of interview. Psychological Assessment 1998, 10(2):120-127.
38. Mauret A.E., Hofmann S.G., Rosenfield D. Catastrophic appraisal and perceived control as moderators of treatment response in panic disorder. International Journal of Cognitive Therapy 2010, 3(3):262-277.
39. Meuret A.E., Rosenfield D., Seidel A., Bhaskara L., Hofmann S.G. Respiratory and cognitive mediators of treatment change in panic disorder: evidence for intervention specificity. Journal of Consulting and Clinical Psychology 2010, 78(5):691-704.
40. Nagayama Hall G.C. Psychotherapy research with ethnic minorities: empirical, ethical, and conceptual issues. Journal of Consulting and Clinical Psychology 2001, 69(3):502-510.
41. Oddone E.Z., Olsen M.K., Lindquist J.H., Orr M., Horner R., Reda D., et al. Enrollment in clinical trials according to patients race: experience from the VA Cooperative Studies Program (1975-2000). Controlled Clinical Trials 2004, 25(4):378-387.
42. Okazaki S. Asian American and White American differences on affective distress symptoms: do symptom reports differ across reporting methods?. Journal of Cross-Cultural Psychology 2000, 31:603-625.
43. Paradis C.M., Freidman S. Sleep paralysis in African Americans with panic disorder. Transcultural Psychiatry 2005, 42:123-134.
44. Paradis, C. M., Friedman, S., & Hatch, M. (1997). Isolated Sleep Paralysis in African Americans with Panic Disorder. Cultural Diversity and Mental Health, 3(1), 69-76. doi:10.1037/1099-9809.3.1.69.
45. Pincus D.B., May J.E., Whitton S.W., Mattis S.G., Barlow D.H. Cognitive-behavioral treatment of panic disorder in adolescence. Journal of Clinical Child & Adolescent Psychology 2010, 39(5):638-649.
46. Pohl R.B., Wolkow R.M., Clary C.M. Sertraline in the treatment of panic disorder: a double-blind multicenter trial. American Journal of Psychiatry 1998, 155(9):1189-1195.
47. Pollack M.H., Otto M.W., Wirthington J.J., Manfro G.G., Wolkow R. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Archives of General Psychiatry 1998, 55:1010-1016.
48. Roy-Byrne P.P., Katon W., Cowley D.S., Russo J. A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Archives of General Psychiatry 2001, 58:869-876.
49. Roy-Byrne P., Russo J., Pollack M., Stewart R., Bystrisky A., Bell J., et al. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder. Psychological Medicine 2003, 33:511-518.
50. Roy-Byrne P., Sherbourne C., Miranda J., Stein M., Craske M., Golinelli D., et al. Poverty and response to treatment among panic disorder patients in primary care. American Journal of Psychiatry 2006, 1419-1425.
51. Roy-Byrne P., Stein M.B., Russo J., Craske M., Katon W., Sullivan G., et al. Medical illness and response to treatment in primary care panic disorder. General Hospital Psychiatry 2005, 27:237-243.
52. Smith L.C., Friedman S., Nevid J. Clinical and sociocultural differences in African Americans and European American patients with panic disorder and agoraphobia. Journal of Nervous and Mental Disease 1999, 187(9):549-560.
53. Smits J.A.J., Powers M.B., Cho Y., Telch M.J. Mechanism of change in cognitive-behavioral treatment of panic disorder: evidence for the fear of fear meditational hypothesis. Journal of Consulting and Clinical Psychology 2004, 72:646-652.
54. Spriggs M. Canaries in the mines: children, risk, non-therapeutic research, and justice. Journal of Medical Ethics 2004, 30:176-181.
55. Statistics Canada (2008). Canada's Ethnocultural Mosaic, 2006 census. Catalogue No. 97-562-X. Minister of Industry: Ottawa, Ontario.
56. Stahl S.M., Gergel I., Li D. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo controlled trial. Journal of Clinical Psychiatry 2003, 64(11):1322-1327.
57. Sue S., Fujino D.C., Hu L.X., Tackeuchi D.X., Zone N. Community mental health services for ethnic minority groups: a test of the cultural responsiveness hypothesis. Journal of Consulting and Clinical Psychology 1991, 59:533-540.
58. Suite D.H., La Bril R., Primm A., Harrison-Ross P. Beyond misdiagnosis, misunderstanding and mistrust: relevance of the historical perspective in the medical and mental health treatment of people of color. Journal of the National Medical Association 2007, 99(8):879-885.
59. Telch M.J., Schmidt N.B., Jaimez T.L., Jacquin K.M., Harrington P.J. Impact of cognitive-behavioral treatment on quality of life in panic disorder patients. Journal of Consulting and Clinical Psychology 1995, 63:823-830.
60. U.S.Department of Health and Human Services, Public Health Service National Institutes of Health: outreach notebook for the NIH guidelines on inclusion of women and minorities as subjects in clinical research 2002, National Institutes of Health (NIH Pub. No. 03-7036), Bethesda, MD.
61. U.S. Department of Health and Human Services (2009). National Institutes of Health: monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research. Comprehensive report: tracking of human subjects research as reported in fiscal year 2007 fiscal year 2008.
62. White K.S., Allen L.B., Barlow D.H., Gorman J.M., Shear M.K., Woods S.W. Attrition in a multicenter trial for panic disorder. The Journal of Nervous and Mental Diseases 2010, 198(9):665-671.
63. Williams, M. T., Beckmann-Mendez, D., & Turkheimer, E. (2012). Cultural barriers to African American participation in anxiety disorders research. Journal of the National Medical Association; in press.
64. Williams K.E., Chambless D.L., Steketee G. Behavioral treatment of obsessive-compulsive disorder in African Americans: clinical issues. Journal of Behavior Therapy and Experimental Psychiatry 1998, 29:163-170.
65. Williams M.T., Proetto D., Casiano D., Franklin M.E. Recruitment of a hidden population: African Americans with obsessive-compulsive disorder. Contemporary Clinical Trials 2012, 33(1):67-75.
66. Williams M., Powers M., Yun Y., Foa E. Minority participation in randomized controlled trials for obsessive-compulsive disorder. Journal of Anxiety Disorders 2010, 24(2):171-177.
67. Wendler D., Kington R., Madans J., Wye G.V., Christ-Schmidt H., Pratt L.A., et al. Are racial and ethnic minorities less willing to participate in health research?. PLoS Medicine 2006, 3(2):e19.